U.S. overdose deaths—67.8% of which involve opioids—decreased last year for the first time in nearly three decades and are projected to decline another 3.4% this year. Other data show opioids are prescribed less often, and at lower dosages, than in the past.
The $205 billion attributable to excess healthcare spending between 2015 and 2018 included providing medical care for opioid addicts and infants born with neonatal opioid-related conditions, and other family members bearing costs associated with those diagnoses.
In this interview, Tim Vanderveen, PharmD, a consultant with ICU Medical, discusses IV therapy and its impact on patient safety.
Because new USP <800> Hazardous Drugs—Handling in Healthcare Settings refers to the other chapters, it is considered by USP to be “informational only” until the revisions are final. The Joint Commission has said it will continue to survey hospitals to the current USP compounding chapters but will expect hospitals to meet the requirements of local AHJs, as always.
USP <800> will still take effect on December 1. The Healthcare Quality and Safety team at USP explained that it would only be “informational and not compendially applicable.”
When given intraspinally instead of a local anesthetic, tranexamic acid is a potent neurotoxin with a mortality rate of about 50% and is almost always harmful to the patient. Survivors of intraspinal tranexamic acid injection often experience seizures, permanent neurological injury, and paraplegia.
The alert newsletter, Quick Safety 48, was released in the April issue of Perspectives amid statistics The Joint Commission cited from both the U.S. Substance Abuse and Mental Health Services Administration and the American Nurses Association, which together suggest that 10% of healthcare workers in the U.S. are abusing drugs of some sort.
In this interview, Michael R. Cohen, RPH, MS, ScD (hon.), DPS (hon.), FASHP, founder and president of the Institute for Safe Medication Practices, discusses the current state of medication safety.
According to the Joint Commission alert, direct oral anticoagulants provide ease of use for patients, but they can lead to bleeding risks that could be serious and potentially life-threatening.
NIOSH recognizes that hazardous drugs are of major concern, estimating that about 8 million U.S. healthcare workers are potentially exposed to them. This figure includes pharmacy and nursing personnel, physicians, operating room personnel, environmental services workers, and shipping and receiving personnel.